Belucie Luxury Essential Twin Pact NO21

Manufacturer: KIMJEONGMOON ALOE CO., LTD. | COSMAX INC.
Effective date: 2012-11-22
Label type: HUMAN OTC DRUG LABEL
Version: 1
Source: full-release
Hydrated at: 2026-05-31 22:33:47

Label at a glance#

ProductBelucie Luxury Essential Twin Pact NO21 SPF25 PA PLUS PLUS

Active ingredientTitanium Dioxide, OCTINOXATE, Zinc Oxide

Label structure8 sections

Indications and uses

Indication and usage 1. Recap the bottle after use. 2. Avoid exposure to a high or low temperature of direct sunlight

Dosage and administration

Dosage and administration After take contents off puff, spread carefully depending on your skin texture.

Label contents#

Full prescribing information#

ACTIVE INGREDIENT

OTC - ACTIVE INGREDIENT SECTION

Active Ingredients: Titanium Dioxide (CI 77891) 6.208%, Ethylhexyl Methoxycinnamate 4%, Zinc Oxide (CI 77947) 1.96%

INACTIVE INGREDIENT

INACTIVE INGREDIENT SECTION

Inactive Ingredients: Talc, Mica (CI 77019), Silica, Alumina, Methyl Methacrylate Crosspolymer, Ethylene/Acrylic Acid Copolymer, Triethylhexanoin, Hydrogenated Castor Oil Isostearate, Magnesium Myristate, HDI/Trimethylol Hexyllactone Crosspolymer, Iron Oxides (CI 77492), Dimethicone, Triethoxycaprylylsilane, Methicone, Iron Oxides (CI 77491), Methylparaben, Iron Oxides (CI 77499), Fragrance(Parfum), Butylparaben, Acorus Gramineus Root/Stem Extract, Ultramarines (CI 77007), Morus Alba Bark Extract, Water, Butylene Glycol, Bacillus/Soybean Ferment Extract, Polyperfluoromethylisopropyl Ether, Aloe Barbadensis Leaf Extract, Chrysanthellum Indicum Extract, Lonicera Japonica (Honeysuckle) Flower Extract, Nelumbo Nucifera Flower Extract, Carthamus Tinctorius (Safflower) Flower Extract, Laminaria Saccharina Extract, Glycerin, Camellia Sinensis Leaf Extract, Angelica Keiskei Leaf/Stem Extract, Rubus Suavissimus (Raspberry) Leaf Extract, Glycine Soja (Soybean) Oil, Lecithin, Alcohol Denat. Human Oligopeptide-1

PURPOSE

OTC - PURPOSE SECTION

Purpose: UVA/UVB Protection

WARNINGS

WARNINGS SECTION

Warnings
1. In case of having following symptoms after using this, you’re advised to stop using it immediately. If you keep using it, the symptoms will get worse and need to consult a dematologists.
2. In case of having problems such as red spots, swelling, itching and irritation during usage
3. In case the above symptoms emerge due to direct exposure to sunlight
4. Please do not apply the skin to areas affected by eczema and dermatitis

KEEP OUT OF REACH OF CHILDREN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

KEEP OUT OF REACH OF CHILDREN

INDICATIONS AND USAGE

INDICATIONS & USAGE SECTION

Indication and usage
1. Recap the bottle after use.
2. Avoid exposure to a high or low temperature of direct sunlight

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

Dosage and administration
After take contents off puff, spread carefully depending on your skin texture.

PACKAGE LABEL. PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Image of carton

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
50410-010-01	2020-01-31	C162847	48780-1	9d75b9d1-169e-f424-e053-dadaa90a57ce	827dfa56-e555-486d-8017-5e72f27d46a8

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
50410-010-01	Belucie Luxury Essential Twin Pact NO21SPF25 PA PLUS PLUS	12 g in 1 CARTON	POWDER	12		1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
50410-010	BELUCIE LUXURY ESSENTIAL TWIN PACT NO21 SPF25 PA PLUS PLUS (TITANIUM DIOXIDE, OCTINOXATE, ZINC OXIDE) POWDER [KIMJEONGMOON ALOE CO., LTD.]	1	Legacy NDC, 1 package rows	20121122_827dfa56-e555-486d-8017-5e72f27d46a8.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
OCTINOXATE	ACTIVE INGREDIENT	4Y5P7MUD51	1
Titanium Dioxide	ACTIVE INGREDIENT	15FIX9V2JP	1
Zinc Oxide	ACTIVE INGREDIENT	SOI2LOH54Z	1
OCTINOXATE	ACTIVE MOIETY	4Y5P7MUD51	1
TITANIUM DIOXIDE	ACTIVE MOIETY	15FIX9V2JP	1
ZINC OXIDE	ACTIVE MOIETY	SOI2LOH54Z	1
Mica	INACTIVE INGREDIENT	V8A1AW0880	1
Talc	INACTIVE INGREDIENT	7SEV7J4R1U	1
Triethylhexanoin	INACTIVE INGREDIENT	7K3W1BIU6K	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 8 matching rows.

Belucie Luxury Essential Twin Pact NO21 SPF25 PA PLUS PLUS
Titanium Dioxide, OCTINOXATE, Zinc Oxide
Titanium Dioxide
OCTINOXATE
Zinc Oxide
Talc
Mica
Triethylhexanoin

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
50410-010	50410-010-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 6 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
Titanium Dioxide	15FIX9V2JP	ACTIM
OCTINOXATE	4Y5P7MUD51	ACTIM
Zinc Oxide	SOI2LOH54Z	ACTIM
Talc	7SEV7J4R1U	IACT
Mica	V8A1AW0880	IACT
Triethylhexanoin	7K3W1BIU6K	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 35 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
Talc	TALC	7SEV7J4R1U	POWDER, FOR SUSPENSION / ORAL		735 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
Talc	TALC	7SEV7J4R1U	TABLET, DELAYED RELEASE / ORAL		349 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
Talc	TALC	7SEV7J4R1U	GRANULE, DELAYED RELEASE / ORAL		525 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
Talc	TALC	7SEV7J4R1U	SUSPENSION, EXTENDED RELEASE / ORAL		46 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
Talc	TALC	7SEV7J4R1U	CAPSULE, COATED, EXTENDED RELEASE / ORAL		20 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
Talc	TALC	7SEV7J4R1U	CAPSULE, DELAYED RELEASE / ORAL		420 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
Talc	TALC	7SEV7J4R1U	TABLET, DELAYED RELEASE PARTICLES / ORAL		56 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
Talc	TALC	7SEV7J4R1U	CAPSULE, EXTENDED RELEASE / ORAL		5119 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
Talc	TALC	7SEV7J4R1U	GUM, CHEWING / BUCCAL	NA		Exact identifier — unii candidate 35 equally ranked IID candidates
Talc	TALC	7SEV7J4R1U	TABLET / BUCCAL	15 mg		Exact identifier — unii candidate 35 equally ranked IID candidates
Talc	TALC	7SEV7J4R1U	GRANULE, FOR SUSPENSION / ORAL		296 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
Talc	TALC	7SEV7J4R1U	CAPSULE, COATED / ORAL		87 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
Talc	TALC	7SEV7J4R1U	TABLET / ORAL	1000 mg		Exact identifier — unii candidate 35 equally ranked IID candidates
Talc	TALC	7SEV7J4R1U	LOZENGE / ORAL		50 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
Talc	TALC	7SEV7J4R1U	OINTMENT / TOPICAL	74.6 %w/w		Exact identifier — unii candidate 35 equally ranked IID candidates
Talc	TALC	7SEV7J4R1U	GRANULE / ORAL		322 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
Talc	TALC	7SEV7J4R1U	CAPSULE, COATED PELLETS / ORAL	14 mg		Exact identifier — unii candidate 35 equally ranked IID candidates
Talc	TALC	7SEV7J4R1U	TABLET, CHEWABLE, EXTENDED RELEASE / ORAL		18 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
Talc	TALC	7SEV7J4R1U	ELIXIR / ORAL	4.5 mg/5ml		Exact identifier — unii candidate 35 equally ranked IID candidates
Talc	TALC	7SEV7J4R1U	POWDER / TOPICAL		9235 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
Talc	TALC	7SEV7J4R1U	TABLET, COATED / ORAL	320.75 mg		Exact identifier — unii candidate 35 equally ranked IID candidates
Talc	TALC	7SEV7J4R1U	PELLET / ORAL		69 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
Talc	TALC	7SEV7J4R1U	TABLET, FILM COATED / ORAL		91 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
Talc	TALC	7SEV7J4R1U	TABLET, FOR SUSPENSION / ORAL		24 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
Talc	TALC	7SEV7J4R1U	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL		357 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
Talc	TALC	7SEV7J4R1U	TABLET, ORALLY DISINTEGRATING / ORAL		80 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
Talc	TALC	7SEV7J4R1U	SUSPENSION / ORAL		234 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
Talc	TALC	7SEV7J4R1U	TABLET, SUGAR COATED / ORAL	NA		Exact identifier — unii candidate 35 equally ranked IID candidates
Talc	TALC	7SEV7J4R1U	TABLET, EXTENDED RELEASE / ORAL		300 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
Talc	TALC	7SEV7J4R1U	TABLET, CHEWABLE / ORAL		202 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
Talc	TALC	7SEV7J4R1U	TABLET, FILM COATED, EXTENDED RELEASE / ORAL		60 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
Talc	TALC	7SEV7J4R1U	TABLET / SUBLINGUAL	32.4 mg		Exact identifier — unii candidate 35 equally ranked IID candidates
Talc	TALC	7SEV7J4R1U	CAPSULE / ORAL		729 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
Talc	TALC	7SEV7J4R1U	TABLET / RECTAL	32.4 mg		Exact identifier — unii candidate 35 equally ranked IID candidates
Talc	TALC	7SEV7J4R1U	DROPS / ORAL	NA		Exact identifier — unii candidate 35 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
8ebf53d8-d29b-46ce-a142-6f94cfffc3db			827dfa56-e555-486d-8017-5e72f27d46a8	2012-11-22	Warnings	Exact identifier spl id: 8ebf53d8-d29b-46ce-a142-6f94cfffc3db spl set id: 827dfa56-e555-486d-8017-5e72f27d46a8

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.